These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35115506)

  • 21. Estimation of the bacteriocin ColE7 conjugation-based "kill" - "anti-kill" antimicrobial system by real-time PCR, fluorescence staining and bioluminescence assays.
    Maslennikova IL; Kuznetsova MV; Toplak N; Nekrasova IV; Žgur Bertok D; Starčič Erjavec M
    Lett Appl Microbiol; 2018 Jul; 67(1):47-53. PubMed ID: 29736984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements.
    Hayashi N; Lai Y; Fuerte-Stone J; Mimee M; Lu TK
    Nat Commun; 2024 Mar; 15(1):2096. PubMed ID: 38453913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.
    Ba F; Zhang Y; Ji X; Liu WQ; Ling S; Li J
    Biotechnol J; 2024 Jan; 19(1):e2300327. PubMed ID: 37800393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering E. coli strains using antibiotic-resistance-gene-free plasmids.
    Amrofell MB; Rengarajan S; Vo ST; Ramirez Tovar ES; LoBello L; Dantas G; Moon TS
    Cell Rep Methods; 2023 Dec; 3(12):100669. PubMed ID: 38086386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulation-Based Engineering of Time-Delayed Safety Switches for Safer Gene Therapies.
    Scott H; Sun D; Beal J; Kiani S
    ACS Synth Biol; 2022 May; 11(5):1782-1789. PubMed ID: 35412812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An efficient platform for genetic selection and screening of gene switches in Escherichia coli.
    Muranaka N; Sharma V; Nomura Y; Yokobayashi Y
    Nucleic Acids Res; 2009 Apr; 37(5):e39. PubMed ID: 19190095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing the SOS Response for Enhanced CRISPR-Cas-Based Recombineering in E. coli through Transient Inhibition of Host RecA Activity.
    Moreb EA; Hoover B; Yaseen A; Valyasevi N; Roecker Z; Menacho-Melgar R; Lynch MD
    ACS Synth Biol; 2017 Dec; 6(12):2209-2218. PubMed ID: 28915012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biocontainment of genetically modified organisms by synthetic protein design.
    Mandell DJ; Lajoie MJ; Mee MT; Takeuchi R; Kuznetsov G; Norville JE; Gregg CJ; Stoddard BL; Church GM
    Nature; 2015 Feb; 518(7537):55-60. PubMed ID: 25607366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.
    Möndel M; Schroeder BO; Zimmermann K; Huber H; Nuding S; Beisner J; Fellermann K; Stange EF; Wehkamp J
    Mucosal Immunol; 2009 Mar; 2(2):166-72. PubMed ID: 19129752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application.
    Ou B; Yang Y; Tham WL; Chen L; Guo J; Zhu G
    Appl Microbiol Biotechnol; 2016 Oct; 100(20):8693-9. PubMed ID: 27640192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells.
    Pickar-Oliver A; Black JB; Lewis MM; Mutchnick KJ; Klann TS; Gilcrest KA; Sitton MJ; Nelson CE; Barrera A; Bartelt LC; Reddy TE; Beisel CL; Barrangou R; Gersbach CA
    Nat Biotechnol; 2019 Dec; 37(12):1493-1501. PubMed ID: 31548729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice.
    Gencay YE; Jasinskytė D; Robert C; Semsey S; Martínez V; Petersen AØ; Brunner K; de Santiago Torio A; Salazar A; Turcu IC; Eriksen MK; Koval L; Takos A; Pascal R; Schou TS; Bayer L; Bryde T; Johansen KC; Bak EG; Smrekar F; Doyle TB; Satlin MJ; Gram A; Carvalho J; Jessen L; Hallström B; Hink J; Damholt B; Troy A; Grove M; Clube J; Grøndahl C; Haaber JK; van der Helm E; Zdravkovic M; Sommer MOA
    Nat Biotechnol; 2024 Feb; 42(2):265-274. PubMed ID: 37142704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.
    Gronbach K; Eberle U; Müller M; Olschläger TA; Dobrindt U; Leithäuser F; Niess JH; Döring G; Reimann J; Autenrieth IB; Frick JS
    Infect Immun; 2010 Jul; 78(7):3036-46. PubMed ID: 20421387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-Mediated Re-Sensitization of Antibiotic-Resistant Escherichia coli Harboring Extended-Spectrum β-Lactamases.
    Kim JS; Cho DH; Park M; Chung WJ; Shin D; Ko KS; Kweon DH
    J Microbiol Biotechnol; 2016 Feb; 26(2):394-401. PubMed ID: 26502735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Multiplex Creation of Escherichia coli Strains Capable of Interfering with Phage Infection Through CRISPR.
    Strotksaya A; Semenova E; Savitskaya E; Severinov K
    Methods Mol Biol; 2015; 1311():147-59. PubMed ID: 25981471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.
    Hare PJ; Englander HE; Mok WWK
    J Appl Microbiol; 2022 Jun; 132(6):4020-4032. PubMed ID: 35332984
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Durmusoglu D; Al'Abri IS; Collins SP; Cheng J; Eroglu A; Beisel CL; Crook N
    ACS Synth Biol; 2021 May; 10(5):1039-1052. PubMed ID: 33843197
    [No Abstract]   [Full Text] [Related]  

  • 38. Specific gene repression by CRISPRi system transferred through bacterial conjugation.
    Ji W; Lee D; Wong E; Dadlani P; Dinh D; Huang V; Kearns K; Teng S; Chen S; Haliburton J; Heimberg G; Heineike B; Ramasubramanian A; Stevens T; Helmke KJ; Zepeda V; Qi LS; Lim WA
    ACS Synth Biol; 2014 Dec; 3(12):929-31. PubMed ID: 25409531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmable bacteria detect and record an environmental signal in the mammalian gut.
    Kotula JW; Kerns SJ; Shaket LA; Siraj L; Collins JJ; Way JC; Silver PA
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4838-43. PubMed ID: 24639514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered Recombinant
    Ou B; Jiang B; Jin D; Yang Y; Zhang M; Zhang D; Zhao H; Xu M; Song H; Wu W; Chen M; Lu T; Huang J; Seo H; Garcia C; Zheng W; Guo W; Lu Y; Jiang Y; Yang S; Kaushik RS; Li X; Zhang W; Zhu G
    ACS Synth Biol; 2020 Feb; 9(2):412-426. PubMed ID: 31944664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.